0000899243-19-009014.txt : 20190327
0000899243-19-009014.hdr.sgml : 20190327
20190327160529
ACCESSION NUMBER: 0000899243-19-009014
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190325
FILED AS OF DATE: 20190327
DATE AS OF CHANGE: 20190327
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Telling Fred
CENTRAL INDEX KEY: 0001382225
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32188
FILM NUMBER: 19708443
MAIL ADDRESS:
STREET 1: 501 ELLIOTT AVE. W.
STREET 2: SUITE 400
CITY: SEATTLE
STATE: WA
ZIP: 98119
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ORAGENICS INC
CENTRAL INDEX KEY: 0001174940
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 593410522
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4902 EISENHOWER BLVD
STREET 2: SUITE 125
CITY: TAMPA
STATE: FL
ZIP: 33634
BUSINESS PHONE: 8132867900
MAIL ADDRESS:
STREET 1: 4902 EISENHOWER BLVD
STREET 2: SUITE 125
CITY: TAMPA
STATE: FL
ZIP: 33634
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-25
0
0001174940
ORAGENICS INC
OGEN
0001382225
Telling Fred
4902 EISENHOWER BOULEVARD
TAMPA
FL
33634
1
0
0
0
Common Stock
2019-03-25
4
P
0
100000
A
339538
D
Series 1 Common Stock Warrants (right to buy)
0.75
2019-03-25
4
P
0
50000
A
2019-03-25
2020-09-25
Common Stock
50000
50000
D
Series 2 Common Stock Warrants (right to buy)
0.90
2019-03-25
4
P
0
50000
A
2019-03-25
2024-03-25
Common Stock
50000
50000
D
Purchase of Units consisting of one share of common stock and Series 1 Warrant to purchase one-half of a share of our Common Stock (exercisable through the earlier of 20 days post read out of AG013 clinical trial data or eighteen months) and a Series 2 Warrant to purchase one-half of a share of our Common Stock in an underwritten public offering at the price of $0.75 per Unit, which was the price paid by the public for such Units.
/s/ Mark A. Catchur, as Attorney-in-Fact for Frederick W. Telling
2019-03-27